We further revealed that S100A8 and S100A9 (S100A8/A9) could serve as predictive biomarkers for ASA-AKI, being significantly upregulated in plasma of ASA-AKI patients at 0 h after surgery by proteomic testing (Wang et al., 2023). Here, S100A8 is linked to acute kidney injury.